参天製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/07/11 | 1,565 | 1,570 | 1,555 | 1,568 | +5 | +0.3% | 846,800 |
2017/07/10 | 1,550 | 1,564 | 1,540 | 1,563 | +19 | +1.2% | 1,572,600 |
2017/07/07 | 1,549 | 1,566 | 1,531 | 1,544 | -17 | -1.1% | 2,679,400 |
2017/07/06 | 1,537 | 1,565 | 1,536 | 1,561 | +35 | +2.3% | 2,176,800 |
2017/07/05 | 1,519 | 1,526 | 1,504 | 1,526 | +8 | +0.5% | 1,034,900 |
2017/07/04 | 1,535 | 1,542 | 1,510 | 1,518 | -10 | -0.7% | 1,042,100 |
2017/07/03 | 1,525 | 1,536 | 1,515 | 1,528 | +4 | +0.3% | 1,004,700 |
2017/06/30 | 1,500 | 1,527 | 1,498 | 1,524 | +17 | +1.1% | 2,052,800 |
2017/06/29 | 1,517 | 1,531 | 1,506 | 1,507 | -13 | -0.9% | 1,280,800 |
2017/06/28 | 1,526 | 1,531 | 1,515 | 1,520 | -8 | -0.5% | 925,300 |
2017/06/27 | 1,536 | 1,549 | 1,525 | 1,528 | -4 | -0.3% | 1,096,900 |
2017/06/26 | 1,517 | 1,534 | 1,511 | 1,532 | +15 | +1% | 723,700 |
2017/06/23 | 1,526 | 1,531 | 1,511 | 1,517 | -9 | -0.6% | 1,208,100 |
2017/06/22 | 1,516 | 1,529 | 1,511 | 1,526 | +29 | +1.9% | 2,094,600 |
2017/06/21 | 1,487 | 1,498 | 1,471 | 1,497 | +5 | +0.3% | 1,609,800 |
2017/06/20 | 1,500 | 1,502 | 1,489 | 1,492 | -1 | -0.1% | 910,800 |
2017/06/19 | 1,479 | 1,503 | 1,478 | 1,493 | +10 | +0.7% | 1,108,500 |
2017/06/16 | 1,505 | 1,516 | 1,477 | 1,483 | -18 | -1.2% | 2,126,200 |
2017/06/15 | 1,486 | 1,511 | 1,485 | 1,501 | +28 | +1.9% | 1,610,000 |
2017/06/14 | 1,485 | 1,491 | 1,473 | 1,473 | +2 | +0.1% | 1,467,300 |
2017/06/13 | 1,470 | 1,481 | 1,463 | 1,471 | -28 | -1.9% | 2,194,600 |
2017/06/12 | 1,500 | 1,502 | 1,484 | 1,499 | -4 | -0.3% | 1,117,200 |
2017/06/09 | 1,501 | 1,510 | 1,492 | 1,503 | -9 | -0.6% | 2,163,200 |
2017/06/08 | 1,526 | 1,527 | 1,509 | 1,512 | -19 | -1.2% | 2,032,100 |
2017/06/07 | 1,550 | 1,553 | 1,528 | 1,531 | -34 | -2.2% | 1,843,800 |
2017/06/06 | 1,584 | 1,584 | 1,550 | 1,565 | -43 | -2.7% | 1,609,200 |
2017/06/05 | 1,574 | 1,616 | 1,564 | 1,608 | +20 | +1.3% | 1,436,300 |
2017/06/02 | 1,580 | 1,590 | 1,562 | 1,588 | +13 | +0.8% | 1,421,100 |
2017/06/01 | 1,533 | 1,576 | 1,530 | 1,575 | +50 | +3.3% | 1,813,600 |
2017/05/31 | 1,525 | 1,553 | 1,517 | 1,525 | +9 | +0.6% | 4,380,600 |
2017/05/30 | 1,530 | 1,533 | 1,508 | 1,516 | +8 | +0.5% | 1,248,800 |
2017/05/29 | 1,520 | 1,523 | 1,504 | 1,508 | ±0 | ±0% | 1,003,900 |
2017/05/26 | 1,495 | 1,516 | 1,495 | 1,508 | +7 | +0.5% | 1,590,600 |
2017/05/25 | 1,498 | 1,503 | 1,487 | 1,501 | ±0 | ±0% | 1,415,600 |
2017/05/24 | 1,517 | 1,517 | 1,492 | 1,501 | -3 | -0.2% | 1,310,900 |
2017/05/23 | 1,508 | 1,518 | 1,501 | 1,504 | -5 | -0.3% | 1,058,200 |
2017/05/22 | 1,506 | 1,518 | 1,501 | 1,509 | +2 | +0.1% | 1,748,300 |
2017/05/19 | 1,522 | 1,522 | 1,502 | 1,507 | -14 | -0.9% | 1,676,700 |
2017/05/18 | 1,517 | 1,528 | 1,507 | 1,521 | +4 | +0.3% | 1,286,700 |
2017/05/17 | 1,533 | 1,550 | 1,505 | 1,517 | -71 | -4.5% | 2,417,800 |
2017/05/16 | 1,570 | 1,591 | 1,564 | 1,588 | +34 | +2.2% | 2,122,300 |
2017/05/15 | 1,520 | 1,559 | 1,520 | 1,554 | +18 | +1.2% | 1,802,800 |
2017/05/12 | 1,523 | 1,549 | 1,507 | 1,536 | +26 | +1.7% | 3,017,700 |
2017/05/11 | 1,600 | 1,606 | 1,503 | 1,510 | -130 | -7.9% | 4,218,400 |
2017/05/10 | 1,630 | 1,654 | 1,623 | 1,640 | +24 | +1.5% | 2,071,000 |
2017/05/09 | 1,611 | 1,633 | 1,609 | 1,616 | ±0 | ±0% | 1,898,900 |
2017/05/08 | 1,600 | 1,621 | 1,596 | 1,616 | +43 | +2.7% | 1,958,200 |
2017/05/02 | 1,556 | 1,585 | 1,549 | 1,573 | -4 | -0.3% | 1,060,300 |
2017/05/01 | 1,578 | 1,580 | 1,550 | 1,577 | +10 | +0.6% | 1,158,000 |
2017/04/28 | 1,557 | 1,571 | 1,553 | 1,567 | +13 | +0.8% | 1,298,700 |
1801~
1850
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「参天薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
参天薬 | 167,000円 | 0.0% | +50.6% | 2.04% | 17.79倍 | 2.00倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
小野薬 | 174,700円 | -3.5% | -50.2% | 4.58% | 14.15倍 | 1.05倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 280,800円 | +18.2% | +4.2% | 1.18% | 19.90倍 | 2.54倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
ツムラ | 485,800円 | +22.6% | +68.1% | 2.80% | 12.94倍 | 1.25倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 427,700円 | +7.3% | -3.8% | 2.10% | 19.85倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
市場注目の銘柄
チャート関連のコラム